# Avidity Biosciences Inc. (RNAM)

Source: https://www.quantisnow.com/company/RNAM
Generated: 2026-11-09T21:31:07.046Z

- Ticker: RNAM
- Exchange: NASDAQ
- IPO year: 2020

## Latest RNAM news and filings

- 2026-03-09 10:02 UTC [SEC Form 15-12G filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-avidity-biosciences-inc-6436060)
- 2026-02-27 20:28 UTC [SEC Form 4] [Chief Human Resources Officer Mccarthy Teresa returned 165,296 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-human-resources-officer-mccarthy-teresa-returned-165296-shares-to-6418670)
- 2026-02-27 20:26 UTC [SEC Form 4] [Director Thompson Tamar returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-thompson-tamar-returned-6692-shares-to-the-company-closing-6418661)
- 2026-02-27 20:24 UTC [SEC Form 4] [Chief Financial Officer Maclean Michael F returned 133,977 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-maclean-michael-f-returned-133977-shares-to-6418651)
- 2026-02-27 20:22 UTC [SEC Form 4] [Director Skerjanec Simona returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-skerjanec-simona-returned-6692-shares-to-the-company-closing-6418646)
- 2026-02-27 20:20 UTC [SEC Form 4] [Chief Medical Officer Hughes Steven George returned 115,857 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-hughes-steven-george-returned-115857-shares-to-6418643)
- 2026-02-27 20:19 UTC [SEC Form 4] [President and CEO Boyce Sarah returned 474,861 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-boyce-sarah-returned-474861-shares-to-the-6418642)
- 2026-02-27 20:17 UTC [SEC Form 4] [Chief Legal Officer Moriarty John B returned 92,054 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-moriarty-john-b-returned-92054-shares-to-6418639)
- 2026-02-27 20:16 UTC [SEC Form 4] [Chief Scientific Officer Flanagan W. Michael returned 150,365 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-flanagan-w-michael-returned-150365-shares-to-6418637)
- 2026-02-27 20:15 UTC [SEC Form 4] [Director Wilson Troy Edward returned 78,802 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-wilson-troy-edward-returned-78802-shares-to-the-company-6418633)
- 2026-02-27 20:13 UTC [SEC Form 4] [Chief Program Officer Gallagher Kathleen P. returned 80,303 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-program-officer-gallagher-kathleen-p-returned-80303-shares-to-6418629)
- 2026-02-27 20:11 UTC [SEC Form 4] [Director Henig Noreen returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-henig-noreen-returned-6692-shares-to-the-company-closing-6418625)
- 2026-02-27 20:05 UTC [SEC Form 4] [Director Kim Jean Jinsun returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-kim-jean-jinsun-returned-6692-shares-to-the-company-6418618)
- 2026-02-27 19:56 UTC [SEC Form 4] [Director Levin Arthur A returned 147,934 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-levin-arthur-a-returned-147934-shares-to-the-company-6418609)
- 2026-02-27 19:51 UTC [SEC Form 4] [Director Kaye Edward M. Md returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-kaye-edward-m-md-returned-6692-shares-to-the-6418601)
- 2026-02-27 19:50 UTC [SEC Form 4] [Director Boess Carsten returned 6,692 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-boess-carsten-returned-6692-shares-to-the-company-closing-6418600)
- 2026-02-27 19:47 UTC [SEC Form 4] [Chief Commercial Officer Mosbrooker Eric returned 79,413 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-mosbrooker-eric-returned-79413-shares-to-the-6418596)
- 2026-02-27 19:47 UTC [SEC Form 4] [Chief Technical Officer Calderaro Charles Iii returned 98,547 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-technical-officer-calderaro-charles-iii-returned-98547-shares-to-6418595)
- 2026-02-27 15:06 UTC [SEC Form 25-NSE filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-avidity-biosciences-inc-6418225)
- 2026-02-27 14:51 UTC [SEC Form POSASR filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-avidity-biosciences-inc-6418203)
- 2026-02-27 14:48 UTC [SEC Form POSASR filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-avidity-biosciences-inc-6418197)
- 2026-02-27 14:45 UTC [SEC Form POSASR filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-avidity-biosciences-inc-6418194)
- 2026-02-27 14:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418183)
- 2026-02-27 14:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418182)
- 2026-02-27 14:32 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418179)
- 2026-02-27 14:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418176)
- 2026-02-27 14:28 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418171)
- 2026-02-27 14:27 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Avidity Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-avidity-biosciences-inc-6418169)
- 2026-02-27 14:13 UTC [SEC Form 8-K] [Avidity Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/avidity-biosciences-inc-filed-sec-form-8-k-notice-of-delisting-6418134)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RNAM
- Earnings history: https://www.quantisnow.com/earnings/RNAM
- Dividend history: https://www.quantisnow.com/dividends/RNAM
- Insider transactions: https://www.quantisnow.com/insiders/RNAM
- Options chain: https://www.quantisnow.com/options/RNAM
- SEC 8-K filings only: https://www.quantisnow.com/company/RNAM/8-k
- RSS and alerts for RNAM: https://www.quantisnow.com/docs/rss-feeds.md